Results of Conservative Surgery for Stage I Lung Cancer

This paper reports our results with sublobar resections for stage I non small cell lung cancer. Sixty-one cases of wedge or segmental resection were compared with 517 standard resections (411 lobectomies and 106 pneumonectomies), performed during the years 1971–88. Operative mortality was 0% in the limited resection group and 4 % (19/517) in the standard resection group; cancer recurrence was detected in 36 % of both groups; actuarial survival at 5 years was 55% versus 48% overall. In 28 patients with pre-existing cardiac or pulmonary co-morbidity, limited resection yielded a similar 5-year survival than standard resection (53 % vs 49 %) with no perioperative deaths (0 vs 6 %). Our data support the experience of other authors on conservative management of stage I lung cancer. Particularly in patients with concomitant cardiopulmonary disease, previous cancer or small peripheral tumors, limited resection combined with adequate nodal staging may be as effective as standard lobar resection with respect to long term survival.

[1]  R. Ginsberg Limited resection in the treatment of stage I non-small cell lung cancer; an overview. , 1989, Chest.

[2]  R. Tsuchiya,et al.  Prognosis and survival in resected lung carcinoma based on the new international staging system. , 1988, The Journal of thoracic and cardiovascular surgery.

[3]  J. Miller,et al.  Limited resection of bronchogenic carcinoma in the patient with marked impairment of pulmonary function. , 1987, The Annals of thoracic surgery.

[4]  J. Cooper,et al.  The Role of Segmental Resection in Lung Cancer: Pulmonary Resections , 1986 .

[5]  J. Wilson,et al.  Wedge resection as an alternative procedure for peripheral bronchogenic carcinoma in poor-risk patients. , 1985, The Journal of thoracic and cardiovascular surgery.

[6]  E. Bergstralh,et al.  Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. , 1984, The Annals of thoracic surgery.

[7]  W. Kutschera Segment Resection for Lung Cancer , 1984, The thoracic and cardiovascular surgeon.

[8]  U. Pastorino,et al.  Impact on Survival of the Extent of Resection in Unrelapsed Lung Cancer , 1983, Tumori.

[9]  R. Smith,et al.  Segmental resection for bronchogenic carcinoma: a surgical alternative for the compromised patient. , 1979, The Annals of thoracic surgery.

[10]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[11]  U. Pastorino,et al.  Lung cancer chemoprevention with retinol palmitate. Preliminary data from a randomized trial on stage Ia non small-cell lung cancer. , 1988, Acta oncologica.

[12]  U. Pastorino,et al.  Effect ofchronic cardiopulmonary disease onsurvival after resection forstage Ialung cancer , 1982 .